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The landmark publication of Rachel
Carson's Silent Spring in 1967 sounded
the alarm for harmful effects ofchem-
icals on wildlife. The 1996 publica-
tion of Our Stolen Future by Theo
Colborn, Dianne Dumanoski, and
John Peterson Myers was a clarion
call for recognition of similar
effects on humans.The authors of
Our Stolen Future revealed how
many ofthe findings in animals cor-
relate with disturbances in normal
reproductive and developmental
processes in humans, citing data from
decades of research on wildlife that traced
birth defects, sexual abnormalities, and
reproductive failures to synthetic chemi-
cals that mimic natural hormones. There
is increasing evidence that environmental
hormones may be linked to increases in
hormone-related cancers, endometriosis,
certain behavioral aberrations, and repro-
ductive effects such as an alarming appar-
ent drop in male sperm counts worldwide
in recent years.
Recent advances in technologies have
extended our ability to detect minuscule
amounts ofchemicals in the body and the
environment, and have enabled scientists
to decipher biochemical processes at the
molecular level. These advances are open-
ing new doors to understanding the com-
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hormones, and the role such
hormones play in initiating tumorigenesis,
causing developmental abnormalities, and
impairing reproduction. Knowledge gained
from this basic research will provide critical
information for developing new clinical
applications, therapies, and prevention
strategies.
The Endocrine System
Along with the nervous system, the
endocrine system, which is composed of
glands that secrete chemical messengers, is
one of two communication systems that
regulate all responses and functions of the
body. Unlike the nervous system, which
sends rapid-fire signals via electrochemical
transmission along neuron conduits to the
brain where they are deciphered and
relayed to appropriate parts ofthe body to
elicit instantaneous responses, the
endocrine system provides cellular instruc-
tions more subtly and slowly via chemical
messengers. Hormones that are produced
in the endocrine glands in one part of the
body travel through the bloodstream until
they encounter special receptors with
which they interact to initiate essential bio-
logical responses in specific target tissues.
Hormones are slow-acting and their effects
tend to persist in the body for long periods
of time. Hormones are also specific. Each
hormone has a unique chemical conforma-
tion that matches a particular receptor pro-
tein at its target cell. When a particular
hormone comes in contact with its specific
receptor, the two fit together as precisely as
a lock and key. However, flexibility is also
a feature of hormones. A particular recep-
tor protein can be present on different
kinds of cells in different organs, which
means the same hormone can be used by
the body to achieve different effects in dif-
ferent tissues. A striking feature of hor-
mones is that dramatic changes in cellular
activity are caused by extremely small
amounts ofchemical.
The major endocrine glands of the
body include the pituitary, which regulates
the other endocrine glands; the thyroid,
which regulates metabolic rate; the
parathyroids, which regulate blood calci-
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um; the adrenals, which regulate the
body's fluid and sodium balance and act as
an emergency warning system in times of
stress; the pancreas, which regulates blood
sugar; the pineal gland, which is believed
to regulate biorhythms and moods and
stimulate the onset of puberty; and the
gonads (ovaries in females and testes in
males), which control the development of
secondary sex characteristics and function-
ing of sex organs. As research continues,
scientists are discovering that other organs
and tissues, including the heart and bones,
contain cells that secrete hormones essen-
tial to normal physiological function.
Androgens and Estrogens
Androgens and estrogens are steroids that
are fat-soluble and can readily pass through
the plasma membranes oftheir target cells.
Once inside the cell, steroid hormones
bind to a receptor protein and form a
receptor-hormone complex that then
enters the cell nucleus and binds to the
DNA. The DNA binding causes a change
in the gene's expression and thus changes
in the cell's activity. Certain steroid hor-
mones stimulate genes to synthesize specif-
ic proteins; others block or repress protein
synthesis. There is an array of hormonally
activated events-including mutations in
DNA nucleotides, alteration ofthe chemi-
cal structure of hormones or their recep-
tors, competition for or blocking ofrecep-
tor binding sites by endogenous or envi-
ronmental chemicals that mimic hor-
mones, and a natural decline in hormone
levels as a result ofaging that can initiate
cellular changes, leading to cancer and
irregularities ofthe reproductive system.
Androgens include the male hormones
testosterone and androsterone and pro-
mote development of male sex characteris-
tics. They also contribute to generalized
anabolic functions of bone growth and
increases in protein synthesis, especially in
muscles. Androgens, like all steroid hor-
mones, are derived from cholesterol. The
principal androgen of the testes is testos-
terone. The production of testosterone is
influenced by gonadotropic hormone dis-
patched from the pituitary gland (tropic
hormones stimulate their target organs to
secrete other hormones), and is regulated
by interstitial-cell stimulating hormone
(ICSH). Negative feedback from certain
concentrations oftestosterone in the blood
lowers or blocks ICSH production. In
adulthood, testosterone is essential for
sperm production.
In the female, the ovaries produce two
groups ofsteroid hormones, estrogens and
progesterone. Estrogens, including estradi-
ol, estrone, and estriol, are extremely
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Protein producers. In a general model, steroid hormones passively enter a cell and bind to a receptor to
form a receptor complex, releasing proteins in the process. Other proteins may also bind to the receptor
complex which permits interactions with specific DNA sites to cause transcription of responsive genes.
important in the development of sec-
ondary sex characteristics and regulation of
the menstrual cycle. Estrogens also influ-
ence libido and the metabolism of elec-
trolytes and nitrogen, and help maintain
pregnancy and prepare the breasts for lac-
tation. Progesterone, which resembles
estrogen chemically, helps regulate changes
that occur during menstruation and influ-
ences the development of fetal membranes
and mammary glands during pregnancy.
Three gonadotropic hormones produced
by the pituitary gland regulate the secre-
tion ofestrogens and progesterone: follicle-
stimulating hormone (FSH), luteinizing
hormone (LH), and prolactin.
Some male and female hormones are
actually secreted by both sexes. Male hor-
mones are secreted in greater quantities
and are more potent when produced by
the male, and the same is true for female
hormones when produced by females.
Hormone Function and Regulation
Hormone production is regulated by a
complicated negative-feedback pathway
that is turned on and off in response to
fluctuating hormone levels. When hor-
mone production peaks, the hormone acts
as an inhibitor and causes the pathway
producing the substance to shut down. At
the top of the chain of command is the
hypothalamus. This part ofthe brairi coor-
dinates signals between the central nervous
and endocrine systems by releasing factors
that initiate a chemical cascade. The cas-
cade switches on subsequent hormone pro-
duction in target cells of other endocrine
glands or tissues in the body.
Once hormones are produced, they
travel through the bloodstream to target
cells where they initiate a change in cellular
activity by attaching to the receptor pro-
tein of certain enzymes. This change is
transmitted across the plasma membrane
of a cell in one of three ways, depending
on the type of hormone. The molecule
may bind to a receptor protein that carries
it across the membrane into the cytoplasm
of the cell. A molecule may move directly
into the nucleus, where it binds to its
receptor protein and initiates transcription
of messenger RNA. In the case of peptide
hormones, which cannot pass through the
plasma membrane, the molecule binds to
receptor proteins on the surface ofthe cell.
Protein receptor binding triggers a change
in the shape of the receptor protein and
unleashes a series of events in the cyto-
plasm. Activation or deactivation ofchem-
ical messages occurs as the signal is passed
from one molecular receptor to the next.
Hormonal Carcinogenesis
Sex hormones and other steroids alter gene
expression in target cells. In the absence of
a steroid, an inhibitor protein prevents the
hormone receptor from binding to the
DNA and inhibits transcription ofmRNA.
But when a steroid binds with its receptor,
it releases the inhibitor protein and the
receptor can bind to regulatory sites on the
DNA, thereby affecting expression of cer-
tain genes and their protein products in
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Toxic actions. Exogenous chemicals may act at hormone receptor sites by mimicking
hormone to create a response or by blocking an endogenous hormone from producing ai
Source: McLachlan JA. Functional toxicology: a new approach to detect biologically active xenobiotics. Env
101:386-387 (1993).
the target cell. Because sex hormones play
important roles in regulating the growth
and differentiation of cells in the sex
organs, changes involving hormones, their
receptors, and transcription factors that
interact with estrogen and androgen recep-
tors may lead to hormonal carcinogenesis.
A hormonal role in carcinogenesis was
first reported by G. T. Beatson in an 1898
Lancetarticle, which described a reduction
of breast cancer in women whose ovaries
had been surgically removed, resulting in
greatly lowered estrogen levels. Subsequent
studies in rodent models and other systems
have repeatedly shown that estrogen
induces tumor formation in various organs
and tissues including the breast, uterus,
prostate, and kidney. Although it is clear
hormones are involved in increased cell
proliferation and hormone-initiated car-
cinogenesis, the biochemical and molecular
mechanisms involved in the initiation and
promotion of tumorigenesis are not fully
understood. Some researchers believe hor-
mones are genotoxic and directly involved
in altering DNA structure; others propose
a more indirect role via oxidation of reac-
tive metabolites formed during sex hor-
mone metabolism.
Androgens. There is debate about
whether hormonally induced cancers result
from direct alteration of genetic material
by hormones (or products of hormone
metabolism) or from an indirect influence
of hormones on DNA via cellular activi-
ties. In order to elucidate the molecular
mechanisms of hormonal carcinogenesis,
Jonathan J. Li, director of the Division of
Etiology and Prevention of Hormonal
Cancers at the Kansas Cancer Institute,
and colleagues have been
estrogen-induced kidney tur
models. Li's group has sho
sure to natural and syntheti(
a cytotoxic effect on cells
damage to kidney tubules.
bility, as evidenced by c
breaks, DNA adducts, and
expression of growth-pror
oncogene products and tun
gene products after exposure
linked to cell proliferation
injury. These findings point
ally mediated epigenetic
steroids rather than a metab
ed genotoxic role in gene r(
Li, "In recent years, the da
lism of estrogen indicate i
much ofa role in carcinogen
Some researchers believ
free radicals-electrically
cules in which the number
not equal to the number ofprotons-gen-
erated by estrogen metabolism may play a
major role in damaging reproductive tract
tissue. Such molecules are unstable and
highly reactive because they must balance
their charges; this reactivity leads to cellu-
IMONAL lar damage and cell death. Over years of
PONSE exposure to free radicals, cumulative dam-
age to reproductive tract tissue could
enhance susceptibility to the onset and
development ofcancerous lesions.
A clear correlation between sex hor-
mones and prostate cancer linked to geno-
toxic activity of estrogens in combination
with androgen was reported by Maarten
C. Boslund, associate professor ofenviron-
mental medicine and urology at the New
York University Medical Center in
EFFECT Tuxedo, New York, in the 1996 book EFFECT Cellular and Molecular Mechanisms of
Hormonal Carcinogenesis: Environmental
Influences. As reported by Boslund, an endogenous administration of testosterone to young, n effect. amnsrto ftsotrn oyug
viron Health Perspect castrated, male rats caused 20-30% devel-
opment of prostate tumors, whereas treat-
investigating ment with testosterone and estrogen com-
mors in rodent bined produced prostate cancer in 100%
wn that expo- of the treated rats. These tumors formed
c estrogens has in regions where there was increased
,, resulting in oxidative tissue damage, signaling a con-
Genetic insta- nection between oxidative damage and
hromosomal carcinogenesis.
inappropriate Shuk-mei Ho, an associate professor of
noting proto- biology at Tufts University, is using a
nor suppressor rodent model system with features of the
to estrogen, is human prostate to study how free radicals
in response to produced by estrogen metabolism can
to a hormon- cause DNA damage and initiate tumorige-
- role for sex nesis. Long-term treatment of Noble rats
olically activat- (a strain highly susceptible to hormone-
egulation. Says induced carcinogenesis) combining andro-
Lta on metabo- gen with estrogen produced an increase
it doesn't play over time in cell proliferation that signifi-
Lesis." cantly exceeded that of rats treated with
re that oxygen androgen alone. In humans, as males age,
charged mole- androgen production declines but estrogen
of electrons is levels remain the same or in some cases
A Noble profession. Scientists are using Noble rats-a strain highly susceptible to hormone-induced carcinogenesis-to study
the role offree radicals in initiating prostate tumors.
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may increase. Increases in prostate cancer
in older men may be related to this modu-
lation of sex hormone levels and concomi-
tant increases in cell damage by metabo-
lites from estrogen oxidation. Ho's
research, published most recently in the
1997 book Prostate: Basic and Clinical
Aspects, shows that enzymes that modulate
tissue destruction by free radicals also have
impaired function in prostate cancer cells,
indicating that there may be a synergistic
relationship between DNA mutation and
metabolic conversion products that causes
cell damage and a proliferation of prostate
carcinogenesis. According to Ho,
"Metabolic conversion can activate a sex
hormone to become a chemical carcinogen
that interacts with and can alter DNA.
Anything in the environment that can
mimic this process will elevate oxidative
stress and cause cancer."
The complexity of how hormones are
related to carcinogenesis is highlighted by
research showing that mutations in the
androgen receptor change the steroid or
DNA-binding activities of that receptor,
which can lead to prostate cancer com-
pletely independent of the hormone.
Dolores J. Lamb, associate professor of
urology and cell biology at the Baylor
College of Medicine, and colleagues have
shown that a mutated androgen receptor
(AR) gene can be activated by an enzyme
in the absence ofandrogen, indicating that
alternative signaling pathways may activate
tumorigenesis.
The importance of the AR gene for
normal sexual development was revealed
by a study offive subjects with ambiguous
reproductive organs. The study was pub-
lished by reproductive biologist Terry
Brown and colleagues from the Division of
Reproductive Biology at Johns Hopkins
University in a 1996 research article in
Molecular and Cellular Endocrinology.
Genetic analysis by Brown found missense
mutations in the AR genes that prevent
androgen-receptor binding to DNA.
Consequently, all five subjects were insen-
sitive to androgen and did not undergo
normal male sexual determination and dif-
ferentiation. Brown's lab has pinpointed
natural mutations in two regions ofthe AR
gene that encode amino acid substitutions
in the DNA-binding domain that are
linked to complete androgen insensitivity.
This work underscores the importance of
the AR gene for normal sexual develop-
ment. Therefore, any chemical that
induces mutation in the AR gene or acts as
an analogue that binds and represses AR
activity may have serious deleterious effects
on embryogenesis.
Estrogens. Estrogen induces the growth
_ _ _~~~~s
Tell-tale signs. In an estrogen expression model, estrogen response elements (EREs) enable mouse
estrogen receptor (mER) to bind to target genes in yeast, producing reporter protein (Z) that can be mea-
sured. Such models are being used to testthe interaction ofthe ER and toxic chemicals.
ofepithelial tissue in the uterus and mam-
mary glands and has been implicated in
breast cancer. Anatomist Gerald Cunha of
the University of California at San
Francisco is investigating the cellular and
molecular mechanisms of steroid sex hor-
mones in the epithelial tissue that lines
reproductive organs. Using genetically
engineered knockout mice that lack the
estrogen receptor (ER) gene, Cunha has
demonstrated that mammary gland growth
is mediated by binding to an ER in the
stroma, or connective tissue of the breast.
Additional experiments using knockout
mice for the ER growth factor indicate
there is a complex molecular pathway of
interactions in which estrogen acts on
mammary stromal cells via the ER to elicit
a crucial estrogen growth factor receptor
that in turn elicits the release of another
factor causing growth of the mammary
epithelial cells. New evidence is showing
how multiple steps in the pathway may be
affected by different chemical compounds
including endogenous proteins and envi-
ronmental toxins, and how injury during
these steps may have various effects on
human health.
Jan-Ake Gustafsson, a medical nutri-
tionist at the Karolinska Institute in
Huddinge, Sweden, is studying how estro-
gen receptors function to modulate the
growth and development ofthe ovaries. In
theJune 1996 issue ofthe Proceedings ofthe
National Academy ofSciences, Gustafsson
characterized two estrogen receptors, ERox
and ER3. Binding to the ER is critical to
the expression of genes that contribute to
normal ovarian function. To determine if
both ER genes are expressed equally in the
ovary, experiments, reported in the
February 1997 issue of Molecular
Endocrinology, were conducted using trans-
genic rats with an ERx knockout gene.
Because ovary follicle growth was present in
rats lacking ERx, it appears that the ovary
expresses estrogen-binding molecules other
than ERx, indicating that ER3 may play a
role in estrogen binding in the ovary.
Comparison ofexpression of the two types
ofERs in the ovary and uterus showed that
higher levels of ERf are expressed in the
uterus and higher levels of ERa are
expressed in the ovaries. Furthermore,
expression ofERs is modulated by the abili-
ty of estrogen to elicit responses in other
target genes such as the progesterone recep-
tor (PR), growth factors, and gonadotropic
hormones. The differences in expression
and relative ligating ability of the different
forms may explain the selectivity of ER
agonists and antagonists, such as follicle-
stimulating hormone (FSH), luteinizing
hormone (LH), or prolactin, in different
target tissues.
An interesting and unexpected devel-
opment of Gustafsson's work in locating
"orphan" receptors-receptors for which
no known ligand has been identified-was
the discovery ofan ER in the prostate. The
group was searching for novel nuclear
receptor proteins and found a new receptor
that had a high affinity for binding estro-
gen. The group has since identified the
human homologue ofthe ER found in the
rat prostate. Whereas estrogen was once
thought to function mainly in reproduc-
tion, discoveries of new estrogen receptors
are signaling important roles for estrogen
related to other aspects of human health,
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such as bone maintenance and the cardio-
vascular system.
Hormone Disrupters
Many environmental chemicals exhibit
estrogenic activity. Some of these chemi-
cals occur naturally in plants and fungi,
others are man-made by-products of man-
ufacturing, present in agricultural and
industrial chemicals. Estrogenic com-
pounds, both environmental and endoge-
nous, may interact with estrogen, estrogen
receptors, or other hormones and tran-
scription factors in the biochemical path-
way ofhormone activity.
George Stancel, professor and vice
chair of the Department of Integrative
Biology, Pharmacology, and Physiology at
the University ofTexas at Houston Health
Science Center, is investigating how the
hormone-receptor complex affects tran-
scription through binding with nucleotide
sequences known as estrogen receptor ele-
ments (EREs). EREs are sequences of 12
nucleotides that enable the receptor to
bind to target genes and are found in the
regulatory regions of hormone-responsive
genes. The finding that there are distinct
EREs for two genes that are members ofa
family of transcription factors (reported in
the October 1995 supplement to EHP) led
Stancel to hypothesize that there are differ-
ent interactions of the ER with DNA
sequences that can initiate transcription of
various nuclear genes in a cell. This could
create different dose-response curves for
various biological responses due to the reg-
ulation ofmultiple genes by estrogens. For
example, environmental estrogens could
bind to an ER and either block or enhance
transcription; they could cause toxicity by
directly altering DNA structure; or they
might be involved in modulating an imbal-
ance in levels of hormonally regulated
growth factors, growth factor receptors,
proto-oncogenes, or other target molecules
in the molecular interactions involved in
growth and differentiation of hormone-
responsive cells.
Numerous examples of reproductive
abnormalities in wildlife caused by environ-
mental contaminants that have estrogenic
properties have been described. In one
instance, alligators exposed to runoffofpes-
ticides in Lake Apopka, Florida, exhibited a
range ofreproductive abnormalities includ-
ing reduced fertility, smaller-than-normal
penises, and shifts in sex ratios with pre-
dominantly females being born.
Diethylstilbestrol (DES), a synthetic
chemical that acts like natural estrogen and
that was widely prescribed to pregnant
women in the 1950s and 1960s to prevent
miscarriage, among other uses, provides an
early example of the effects of hormone-
disrupting chemicals on humans. Years
later, young women who were exposed to
DES in utero had high incidences ofvagi-
nal cancer and experienced sterility and
reproductive tract abnormalities.
Research in the 1970s by environmen-
tal toxicologistJohn McLachlan, director of
the Tulane/Xavier Center for Bioenviron-
mental Research in New Orleans,
Louisiana, showed how animal studies pro-
vide clinically relevant signals for effects of
hormone disruptors in humans. McLachlan
replicated similar reproductive effects of
DES in experimental mouse models. DES-
exposed female mice had increased rates of
vaginal cancer, and exposed male mice
exhibited reduced fertility, undescended or
stunted testicles, and genital tumors. The
link between animal studies and humans
gained significance years later when large
numbers of adults who had prenatal expo-
sure to DES had difficulties having children
and developed cancers. More recently,
McLachlan has investigated the possibility
ofsynergistic interactions between environ-
mental estrogens. Although xenobiotic hor-
mones normally have a much lower bind-
ing affinity than the body's own natural
estrogen, exposure to combinations ofsome
chemical mixtures may cause a dramatic
rise in estrogenic activity. In experiments
by McLachlan and colleagues, reported in
the 7 June 1996 issue of Science, a combi-
nation of the weakly estrogenic pesticides
endosulfan, dieldrin, toxaphene, and chlor-
dane, measured by yeast cell ER binding
assays, produced estrogenic activity
150-1,600 times greater than for any ofthe
chemicals alone. Synergistic responses were
also observed in mammalian cell culture
experiments. According to McLachlan,
such magnification of effect signals the
potential for an extreme health hazard to
humans who are exposed to combinations
of specific environmental chemicals. In
addition to greatly magnified quantitative
effects, synergism can amplify qualitative
effects when different chemicals act on dif-
ferent signaling pathways involved in the
hormone action in target cells.
In a technical comment on McLachlan's
study, published in the 17 January 1997
issue of Science, Kavita Ramamoorthy and
colleagues in the Texas A&M University
Department ofVeterinary Physiology and
Pharmacology reported their failure to repli-
cate synergistic interactions between dieldrin
and toxaphene in ER-binding experiments in
immature female mice, human breast cancer
cell lines, andyeast assays. The group's results
indicated that estrogenic effects are additive
rather than synergistic, and therefore mix-
tures of two compounds can be expected to
be weakly estrogenic and will not have a dra-
matic adverse environmental and human
health impact. Because of the concern over
harmful effects of environmental chemicals,
the conflicting results ofthe two laboratories'
studies have sparked a heated debate about
synergistic effects of organochlorine pesti-
cides. However, as McLachlan and colleagues
point out in a reply to Ramamoorthy in the
same issue ofScience, there are important dif-
ferences in the design of the experiments
conducted in the two labs that may ultimate-
ly shed new light on the complexity of the
molecular biology ofhormone interactions.
Clinical Implications
As data emerge from many avenues, con-
cerns about the risks to human health
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The interaction of a cell with an endogenous or environmental signal (A) produces a response. The inter-
action of a cell with a combination of environmental and endogenous signals (B,C, or D) may result in a
synergistic response.
Source: Arnold SF, McLachlan JA. Synergistic signals in the environment. Environ Health Perspect 104:1020-1022 (1996).
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posed by endocrine disruptors have led to
the identification of many such environ-
mental chemicals. Objectives of ongoing
research are to continue to identify poten-
tially harmful chemicals, define molecular
and physiological mechanisms of action,
clarify mutagenic properties and genetic
susceptibility, specify risk factors from
exposure, and develop therapies and pre-
vention strategies.
Assay for toxicity screening.
McLachlan's group is developing ways to
characterize estrogenic properties of envi-
ronmental chemicals that would parallel
the diagnostic capabilities of the Ames
test used in screening chemicals for car-
cinogenicity. The group has developed
three types of in vitro tests that have
yielded promising results. A yeast estro-
gen screen (described in the May 1996
issue of EHP) was developed to measure
enzyme levels from transcription of the
human ER (hER) and two estrogen
response elements linked to a reporter
gene in yeast. Direct interaction of a
chemical compound with hER is tested
first in a competition binding assay. Next,
estrogenic activity is measured in an
estrogen-sensitive, transgenic human
breast cancer cell line that carries two
EREs linked to the luciferase reporter
gene. Using this method to screen for the
known xenoestrogens DES and DDT
showed enhanced enzyme activity.
McLachlan advocates the use of in vitro
assays in conjunction with whole-animal
models to evaluate environmental chemi-
cals for hormone-disrupting capabilities.
Biomarkers ofexposure. Oncologist
Saraswati Sukumar of the Johns Hopkins
Oncology Center is working on finding a
genetic marker for the early detection of
breast cancer. The ends of chromosomes,
called telomeres, carry a specific set of
DNA nucleotides that ensure the integrity
of the chromosome. If the ends of the
chromosome are broken or damaged, these
nucleotides can become "sticky" and fuse
with other chromosomes, causing mis-
alignments and rearrangements of genetic
material. In response to such damage, the
cell produces lots of telomerase, the
enzyme involved in repairing telomeres.
Because this process occurs in cancer cells
and not in normal human cells, Sukumar's
group is measuring levels of telomerase
activity in the fluid of cancer cells as a
potential biomarker for breast cancer by
investigating induction oftelomerase activ-
ity in rat models following exposure to the
carcinogenic compound N-methyl-N-
nitrosourea.
Work on tumor-suppressor genes by
Carrie W. Rinker-Schaeffer, director of
urologic research and associate director of
the Prostate Cancer Program at the
University of Chicago Cancer Research
Center, may lead to biomarkers for detect-
ing the onset of prostate cancer.
Identification of the KAII gene on chro-
mosome 11, which suppresses prostate
tumor metastasis, has enabled Rinker-
Schaeffer to study expression of this gene
in comparative assays using normal human
cells with prostate cancer cell lines. KAII
RNA is strongly expressed in normal cells,
but down-regulated in cancer cells, so it
may provide a molecular tool to screen for
prostate cancer. According to Rinker-
Schaeffer, "Every three minutes an
American man is diagnosed with prostate
cancer, and every hour four men will die of
this disease. The enormity ofthis problem
demonstrates the critical need for markers
that will allow for accurate diagnosis and
treatment.
Treatment strategies. It is well estab-
lished that estrogen enhances cell growth
and proliferation in breast cancer. A first-
line chemotherapy in the treatment ofhor-
mone-dependent breast cancer is to block
estrogen activity with the drug tamoxifen.
Although initially effective, patients devel-
op a resistance and disease progression
resumes. Angela Brodie, professor ofphar-
macology and experimental therapeutics at
the University of Maryland School of
Medicine, is developing new therapies
based on mechanisms of action for hor-
mones and hormone receptors. Brodie is
interested in two pharmacologic approach-
es to reducing estrogen effects: inhibition
ofestrogen activity with antiestrogens that
bind ERs in the tumor, and inhibition of
estrogen production using chemicals that
block the production of aromatase, an
enzyme that synthesizes estrogen. A variety
ofaromatase inhibitors undergoing clinical
testing promise to lead to new drugs for
the treatment ofbreast cancer.
Prevention strategies. Phytoestrogens,
naturally occurring estrogens found in
plants, have been used for thousands of
years by indigenous medical practitioners.
In contrast to xenoestrogens from industri-
al pollutants that bioaccumulate in animal
and human tissues and may cause adverse
health effects, phytoestrogens have a long
history of coevolution with humans and
animals and are quickly metabolized by
endogenous enzymes. The low incidence
of hormone-related cancers, osteoporosis,
heart disease, and menopausal symptoms
in certain populations with diets rich in
phytoestrogens has led to renewed interest
in the potential beneficial effects of phy-
toestrogens in treating and preventing dis-
ease. Asian populations consume a diet
rich in soy products, which contain the
phytoestrogens genistein and daidzein.
Because of evidence of lesser incidence
among such populations of hormonally
related cancers, and because there is a
greater incidence of hormonally related
cancers among Asians who have migrated
to the United States and consequently
changed their dietary habits, it seems pos-
sible that phytoestrogens in the diet may
be useful in the prevention ofcertain estro-
gen-related diseases.
Evidence to support this thesis was
provided by Coral Lamartiniere, professor
ofpharmacology and toxicology and direc-
tor of the graduate training program in
toxicology at the University of Alabama,
who showed that genistein, an isoflavone
phytoestrogen, protects against chemically
induced mammary cancer in an animal
model. Neonatal and prepuberty rats were
exposed to genistein by injection. In early
adulthood, treated rats were dosed with a
high concentration of the carcinogen
dimethylbenz[a]anthracene (DMBA). A
50% reduction in development of tumors
was observed in genistein-exposed rats, and
there was a longer latency period for tumor
development. Results from subsequent
experiments soon to be published reveal
that protection against DMBA-induced
mammary cancer by phytoestrogens is
dose-dependent. In contrast with deleteri-
ous effects on reproductive development
from neonatal exposure to xenohormones,
early exposure to phytoestrogens may con-
fer protection against breast cancer later in
life. As Lamartiniere points out, "For the
longest time, scientists have viewed expo-
sures to external chemicals during the pre-
natal period as potential for toxicity, but
this opens the opportunity for beneficial
(programming' against future exposures to
environmental toxins."
New technologies and approaches,
including enhanced tools for understand-
ing molecular interactions and mecha-
nisms, are helping scientists to understand
the often powerful effects-both adverse
and beneficial-that very small amounts of
environmental hormones and hormone-
like chemicals may have on humans and
wildlife. Scientists exploring the endocrine
system and the ramifications ofits interac-
tions with environmental chemicals will
ultimately provide the basis for determin-
ing risk factors from exposure, promote
debate, and generate public policy in
regard to the use and distribution ofchem-
icals in the environment.
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